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EDITORIAL
The times, they are a-changin’; a fundamental change to perioperative  
cardiac risk stratification for noncardiac surgery
Preoperative cardiac risk stratification for noncardiac surgery was 
officially formalised with the publication of the American College of 
Cardiology/American Heart Association Task Force Practice Guidelines in 
1996.1 This landmark publication, set the foundation for all subsequent 
risk stratification guidelines for noncardiac surgery. The guideline was 
built around three pillars; i) the patient’s risk factors or comorbidities, 
ii) the patient’s functional capacity and iii) the risk associated with 
the surgical procedure.1 Despite, the limited evidence to inform these 
original guidelines, they provided sensible guidance in the management 
of noncardiac surgical patients at cardiac risk. Subsequent, iterations of 
the guidelines,2-4 continued to follow and re-inforce the importance of 
the three pillars identified in the original guidelines.1 Importantly, this 
philosophical approach to cardiac risk stratification crossed the Atlantic 
and was adopted in Europe too.5, 6
However with time, and accumulating evidence, the foundations 
of the pillars on which these guidelines of perioperative cardiac risk 
stratification for noncardiac surgery had been built, were slowly being 
eroded. Firstly, the evidence that functional capacity could successfully 
discriminate between patients at risk of cardiac events from those who 
aren’t, has been questionable for a while.7 It was the data from the 
Gupta MICA (myocardial infarction and cardiac arrest) model,8 which 
allowed a demonstration of the limitations of functional capacity in risk 
stratification in these patients.9 Secondly, although the majority of the 
cardiac risk factors identified in the original guideline1 have continued to 
be associated with adverse cardiac events,10, 11 the evidence has shown 
that they discriminate poorly between patients at intermediate risk 
for adverse cardiac events. The addition of B-type natriuretic peptides 
however significantly improves clinical risk stratification in these difficult 
patients.12, 13 Subsequently, B-type natriuretic peptides have shown 
clinical utility in preoperative risk stratification for all noncardiac surgical 
patients.14 Finally, it is now clear that over ¾ of patients are asymptomatic 
in the postoperative period, even in the presence of a myocardial injury 
following noncardiac surgery which is independently associated with 30 
day mortality.15 This would suggest that routine postoperative troponin 
screening should be considered in patients at risk of cardiac events.16 
To this end the Canadian Cardiovascular Society have produced their 
first guidelines on the preoperative evaluation of the cardiac patient for 
noncardiac surgery.17 This guideline has been the first to integrate the 
three major developments highlighted above, which have continued to 
erode all other guidelines; they have removed functional capacity as a 
discriminator, they have included preoperative B-type natriuretic peptide 
risk stratification, and finally, they have also included postoperative 
troponin screening for at-risk patients.17 
The times are certainly a-changin’ and this guideline is a major deviation 
from what we have grown up with.1-4 This is a timeous and necessary 
change. It is hoped that the Canadian guidelines will encourage future 
guideline committees from both the United States and Europe to 
reconsider the weight of the evidence which underpin their guidelines, 
and consider moving away from the dogma and philosophy which was 
once useful, but now appears to be holding them back. 
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